Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial
- Resource Type
- Article
- Authors
- Furie, Richard A ; Morand, Eric F; Bruce, Ian N; Manzi, Susan; Kalunian, Kenneth C; Vital, Edward M; Lawrence Ford, Theresa; Gupta, Ramesh; Hiepe, Falk; Santiago, Mittermayer; Brohawn, Philip Z; Berglind, Anna; Tummala, Raj
- Source
- In The Lancet Rheumatology December 2019 1(4):e208-e219
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2665-9913